Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SA Douglas
GSK1562590, a Slowly Dissociating Urotensin-Ii Receptor Antagonist, Exhibits Prolonged Pharmacodynamic Activity Ex Vivo
British Journal of Pharmacology
Pharmacology
Related publications
Effects of Urotensin II and Its Specific Receptor Antagonist Urantide on Rat Vascular Smooth Muscle Cells
Bosnian Journal of Basic Medical Sciences
Medicine
Urotensin II Evokes Potent Vasoconstriction in Humansin Vivo
British Journal of Pharmacology
Pharmacology
Honokiol as a Specific Collagen Receptor Glycoprotein VI Antagonist on Human Platelets: Functional Ex Vivo and in Vivo Studies
Scientific Reports
Multidisciplinary
Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists
In Vivo Pharmacodynamic Activity of the Glycopeptide Dalbavancin
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Protein Expression of Urotensin II, Urotensin-Related Peptide and Their Receptor in the Lungs of Patients With Lymphangioleiomyomatosis
Peptides
Biochemistry
Endocrinology
Physiology
Cellular
Molecular Neuroscience
Scintillation Proximity Assay as a High-Throughput Method to Identify Slowly Dissociating Nonpeptide Ligand Binding to the GnRH Receptor
Journal of Biomolecular Screening
Molecular Medicine
Pharmacology
Biochemistry
Analytical Chemistry
Biotechnology
Drug Discovery
Ex Vivo Interleukin 1 Receptor Antagonist Production on Lipopolysaccharide Stimulation Is Associated With Rheumatoid Arthritis and With Joint Damage
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Urotensin II: An Inflammatory Cytokine
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes